Search results
Factbox-Battles over CEO pay across the globe
Reuters via Yahoo Finance· 13 hours agoHere are other CEO pays that have faced a tough fight: Year Company Description 2024 AstraZeneca Over a third of AstraZeneca's investors opposed its 2024...
Journey to the center of the mirth
Politico· 2 days agoLet’s get into it. In today’s edition: → A military who’s who strutted around an airport-adjacent convention center. → First in Playbook: A pandemic vaccine contract inked with AstraZeneca ...
Raleigh facility plays key role in $245M collaboration - Triangle Business Journal
The Business Journals· 2 days agoA biotech manufacturing facility in Raleigh is a key part of a collaboration between global...
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
KTLA-TV Los Angeles· 2 days agoAs of the close of business on April...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga· 2 days agoTuesday, the FDA approved Amgen Inc AMGN Bkemv (eculizumab-aeeb) as the first interchangeable...
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have...
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report...
Benzinga· 4 days agoWestern pharmaceutical companies and investors are driving a record number of licensing deals with...
AstraZeneca, Daiichi Sankyo's Experimental Lung Cancer Drug Shows Improvement in Patients
Market Watch· 4 days agoAstraZeneca said its experimental drug for non-small cell lung cancer, jointly developed with Japan's Daiichi Sankyo, showed improvement in progression-free survival in its ...
Feds plan for smoother access to RSV infant shot
Politico· 2 days agoThe government has repeatedly met with vaccine makers AstraZeneca and Sanofi in recent months to ensure there is enough supply early in the season after unanticipated demand ...
Cellectis Reports Financial Results for First Quarter 2024
Morningstar· 3 days ago• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca • Cash position of $143 million as of March 31, 20241; cash runway projection ...
